Article
Combinatorial Approaches to the Treatment of Advanced Melanoma.
Hematology/oncology clinics of North America - 1 Feb 2021
Munhoz Rodrigo Ramella, Postow Michael Andrew
Abstract excerpt
The treatment landscape for patients with advanced melanoma has dramatically improved over the past decade, leading to unprecedented survival. Despite the robust activity of single-agent immune-checkpoint blockade with anti-CTLA-4 or anti-PD-1 agents, and the efficacy of targeted therapies capable of interrupting aberrant signaling resulting from BRAF mutations, the benefit from these therapies is not universal....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
